Integral Diagnostics Limited (ASX:IDX – Get Free Report) insider Ingrid Player purchased 25,000 shares of the business’s stock in a transaction on Friday, February 27th. The stock was purchased at an average cost of A$2.42 per share, with a total value of A$60,400.00.
Integral Diagnostics Price Performance
The company has a quick ratio of 1.84, a current ratio of 0.63 and a debt-to-equity ratio of 124.07. The company has a market capitalization of $880.11 million, a price-to-earnings ratio of 62.71, a PEG ratio of 1.39 and a beta of 0.14.
Integral Diagnostics Announces Dividend
The business also recently announced a Interim dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Wednesday, April 1st will be given a dividend of $0.033 per share. The ex-dividend date is Tuesday, March 3rd. This represents a yield of 137.0%. Integral Diagnostics’s payout ratio is presently -28.08%.
Integral Diagnostics Company Profile
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Featured Stories
- Five stocks we like better than Integral Diagnostics
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
- What central banks are doing with gold right now
Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
